catridecacog 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
blood coagulation factors 5134 606138-08-3

Description:

MoleculeDescription

Synonyms:

  • catridecacog
  • catridecacog (genetical recombination)
  • recombinant coagulation factor XIII
  • NovoThirteen
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Sept. 3, 2012 EMA Novo Nordisk A/S

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B02BD11 BLOOD AND BLOOD FORMING ORGANS
ANTIHEMORRHAGICS
VITAMIN K AND OTHER HEMOSTATICS
Blood coagulation factors

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hereditary factor XIII A subunit deficiency indication 439455002




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
NU23Q531G1 UNII
C3709760 UMLSCUI
CHEMBL2108282 ChEMBL_ID
D10532 KEGG_DRUG
DB09310 DRUGBANK_ID
8817 INN_ID
1488293 RXNORM
30297 MMSL
015338 NDDF
22771000122108 SNOMEDCT_US
898202008 SNOMEDCT_US

Pharmaceutical products:

None